West Pharmaceutical Services (WST)
(Delayed Data from NYSE)
$239.26 USD
0.00 (0.00%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $239.18 -0.08 (-0.03%) 7:58 PM ET
1-Strong Buy of 5 1
D Value C Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, West Pharmaceutical Services, Inc. has a market cap of $17.20B, which represents its share price of $239.26 multiplied by its outstanding shares number of 71.91M. As a large-cap company, WST's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
WST 239.26 0.00(0.00%)
Will WST be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for WST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WST
OPK Stock Slips Following Q2 Earnings Miss, Gross Margin Expands
TMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up
WST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Teladoc Health Q2 Loss Narrower Than Expected on Declining Expenses
GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
Other News for WST
Altria Among 6 Dividend Kings To Announce Annual Payout Increases In August
West Pharmaceutical: Q2 Earnings Suggest Recovery
Baron Asset Fund Q2 2025 Shareholder Letter
West Pharmaceutical Services Inc (WST)'s Winning Formula: Financial Metrics and Competitive ...
Best Dividend Aristocrats For August 2025